The American Society for Transplantation and Cellular Therapy presented awards to researchers in the field of transplantation and cellular therapy at the tandem meetings of ASTCT and the Center for International Blood and Marrow Transplant Research.
Patients can die if they take certain previously prescribed beta-blockers during a hematopoietic cell transplant due to suppressed signals from nerves that promote bone marrow regeneration, according to scientists at the Children’s Medical Center Research Institute at UT Southwestern, published in Cancer Discovery, builds upon previous CRI research by analyzing retrospective patient data to correlate beta-blocker use with significantly worse patient outcomes.
